ChemoMetec A/S (CHEMM) - Total Liabilities
Based on the latest financial reports, ChemoMetec A/S (CHEMM) has total liabilities worth Dkr130.78 Million DKK (≈ $20.46 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See ChemoMetec A/S liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
ChemoMetec A/S - Total Liabilities Trend (2004–2025)
This chart illustrates how ChemoMetec A/S's total liabilities have evolved over time, based on quarterly financial data. Check ChemoMetec A/S liquid asset ratio to evaluate the company's liquid asset resilience ratio.
ChemoMetec A/S Competitors by Total Liabilities
The table below lists competitors of ChemoMetec A/S ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hanall Biopharma
KO:009420
|
Korea | ₩44.17 Billion |
|
CCL Products (India) Limited
NSE:CCL
|
India | Rs19.82 Billion |
|
Lotus Pharmaceutical Co Ltd
TW:1795
|
Taiwan | NT$84.28 Billion |
|
Capital Southwest Corporation
NASDAQ:CSWC
|
USA | $1.26 Billion |
|
NV5 Global Inc
NASDAQ:NVEE
|
USA | $440.77 Million |
|
Adecoagro S.A
F:ACD
|
Germany | €3.37 Billion |
|
Advtech
JSE:ADH
|
South Africa | ZAC4.68 Billion |
|
FAP Agri Tbk PT
JK:FAPA
|
Indonesia | Rp6.19 Trillion |
Liability Composition Analysis (2004–2025)
This chart breaks down ChemoMetec A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of ChemoMetec A/S.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.93 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ChemoMetec A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ChemoMetec A/S (2004–2025)
The table below shows the annual total liabilities of ChemoMetec A/S from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | Dkr154.69 Million ≈ $24.20 Million |
+38.91% |
| 2024-06-30 | Dkr111.36 Million ≈ $17.42 Million |
-10.87% |
| 2023-06-30 | Dkr124.93 Million ≈ $19.55 Million |
-13.28% |
| 2022-06-30 | Dkr144.07 Million ≈ $22.54 Million |
+80.24% |
| 2021-06-30 | Dkr79.93 Million ≈ $12.51 Million |
+32.41% |
| 2020-06-30 | Dkr60.37 Million ≈ $9.44 Million |
-6.95% |
| 2019-06-30 | Dkr64.87 Million ≈ $10.15 Million |
+58.29% |
| 2018-06-30 | Dkr40.98 Million ≈ $6.41 Million |
+23.29% |
| 2017-06-30 | Dkr33.24 Million ≈ $5.20 Million |
-0.86% |
| 2016-06-30 | Dkr33.53 Million ≈ $5.25 Million |
+95.90% |
| 2015-06-30 | Dkr17.12 Million ≈ $2.68 Million |
+150.97% |
| 2014-06-30 | Dkr6.82 Million ≈ $1.07 Million |
-9.93% |
| 2013-06-30 | Dkr7.57 Million ≈ $1.18 Million |
+7.71% |
| 2012-06-30 | Dkr7.03 Million ≈ $1.10 Million |
-12.88% |
| 2011-06-30 | Dkr8.07 Million ≈ $1.26 Million |
-20.04% |
| 2010-06-30 | Dkr10.09 Million ≈ $1.58 Million |
+14.00% |
| 2009-06-30 | Dkr8.85 Million ≈ $1.38 Million |
+103.92% |
| 2008-06-30 | Dkr4.34 Million ≈ $679.18K |
-64.26% |
| 2007-06-30 | Dkr12.15 Million ≈ $1.90 Million |
-21.78% |
| 2006-06-30 | Dkr15.53 Million ≈ $2.43 Million |
-19.35% |
| 2005-06-30 | Dkr19.25 Million ≈ $3.01 Million |
+26.21% |
| 2004-06-30 | Dkr15.26 Million ≈ $2.39 Million |
-- |
About ChemoMetec A/S
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, an… Read more